Acadia Pharmaceuticals ACAD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 91.5%-0.2pp | 91.7%-0.2pp | 91.9%-0.1pp | 92%-0.1pp | 92%+0.6pp | |
| Operating margin | 7.4%-2.4pp | 9.8%-13.2pp | 23%-0.2pp | 23.2%-0.3pp | 23.6%-0.5pp | |
| Net margin | 34.3%-2.2pp | 36.5%+11.5pp | 24.9%+3.1pp | 21.8%-1.2pp | 23%-0.7pp | |
| Returns | ||||||
| Return on equity | 37.3%-2.6pp | 39.9%+4.9pp | 35%+1.8pp | 33.2%-4.1pp | 37.2%-1.7pp | |
| Return on invested capital | 10%-3.4pp | 13.4%-25.4pp | 38.8%+0.4pp | 38.4%-5.6pp | 44%-8.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×-0.1× | 0.9×0.0× | 1×-0.1× | 1×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.6×-0.2× | 3.8×+0.8× | 3×+0.1× | 2.9×0.0× | 2.9×+0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -2.5×-1.4× | -1.1×-0.3× | -0.8×0.0× | -0.8×-0.1× | -0.7×+0.4× | |
| Per Share | ||||||
| Book value per share | $7.230.0% | $7.22+34.4% | $5.38+10.3% | $4.88+6.8% | $4.56+3.6% | |
| Valuation | ||||||
| Market capitalization | $3.8B-16.0% | $4.52B+25.5% | $3.6B-4.0% | $3.75B+35.4% | $2.77B-9.3% | |
| Price / earnings | 10.1×-1.5× | 11.6×-2.2× | 13.8×-3.1× | 16.9×+4.8× | 12.1×-1.4× | |
| Price / sales | 3.5×-0.8× | 4.2×+0.8× | 3.4×-0.2× | 3.7×+0.9× | 2.8×-0.4× | |
| Price / book | 3×-0.6× | 3.7×-0.2× | 3.9×-0.6× | 4.6×+0.9× | 3.6×-0.5× | |
| EV / EBITDA | 38.4×+0.8× | 37.7×+24.4× | 13.3×-0.9× | 14.2×+3.7× | 10.5×-0.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Acadia Pharmaceuticals's profit margins?
- Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
- Where do Acadia Pharmaceuticals's ratios come from?
- Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.